James Molloy
Stock Analyst at Alliance Global Partners
(0.04)
# 4,664
Out of 4,676 analysts
291
Total ratings
29.1%
Success rate
-15.7%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNXP Tonix Pharmaceuticals Holding | Reiterated: Buy | $65 | $13.66 | +375.84% | 38 | Aug 24, 2026 | |
| PTHS Pelthos Therapeutics | Reiterated: Buy | $45 | $27.20 | +65.44% | 44 | Aug 24, 2026 | |
| QNRX Quoin Pharmaceuticals | Reiterated: Buy | $35 | $5.07 | +590.34% | 5 | Aug 17, 2026 | |
| INTS Intensity Therapeutics | Reiterated: Buy | $30 → $15 | $4.90 | +206.44% | 7 | Aug 11, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $9 | $4.11 | +118.98% | 7 | Aug 7, 2026 | |
| SNGX Soligenix | Maintained: Buy | $1.5 | $0.4051 | +270.28% | 11 | Aug 7, 2026 | |
| BRNS Barinthus Biotherapeutics | Maintained: Buy | $7 → $6 | $0.66 | +809.09% | 8 | Aug 6, 2026 | |
| ADIL Adial Pharmaceuticals | Initiated Coverage: Buy | $11 | $5.82 | +89.00% | 1 | Aug 3, 2026 | |
| HELP Cybin | Reiterated: Buy | $30 → $15 | $13.99 | +7.26% | 7 | Jul 14, 2026 | |
| SLS SELLAS Life Sciences Group | Reiterated: Buy | $10 → $25 | $14.09 | +77.43% | 10 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.08 | +154.24% | 8 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $3.75 | +380.00% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.29 | +365.12% | 3 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.49465 | +5,964.89% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.13 | +430.97% | 10 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $1.23 | +184.55% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $33.91 | +62.19% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $5.08 | +77.17% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.21 | +222.06% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.41 | +609.22% | 5 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.66 | +622.89% | 5 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.2375 | +1,584.21% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.43 | +188.07% | 6 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.5 | $0.2215 | +1,931.60% | 8 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 | $0.3823 | +1,861.81% | 4 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 | $7.87 | +3,457.81% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $213 | $0.6419 | n/a | 4 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 → $84 | $5.80 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $4.5 | $3.32 | n/a | 3 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19.38 | $3.09 | n/a | 3 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $490 | $5.65 | n/a | 3 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.5 | $4.00 | n/a | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.5 | $0.3046 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $5.40 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.2 | $0.27 | n/a | 1 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $2.46 | n/a | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $1.21 | n/a | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.17 | n/a | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.75 → $3.5 | $0.254 | n/a | 2 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.5 | $0.0001 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $0.074 | n/a | 1 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $7 | $1.46 | n/a | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $5.89 | n/a | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.8008 | n/a | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.1831 | n/a | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $4 | $1.66 | n/a | 2 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.48 | n/a | 1 | Jul 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $16 | $0.001 | n/a | 6 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $40 | $5.21 | n/a | 2 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.5 | $0.9317 | n/a | 2 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.5 → $11 | $0.00001 | n/a | 2 | Apr 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $0.0007 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $5.10 | n/a | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $7.91 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $0.06515 | n/a | 1 | Oct 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $30 | $1.82 | n/a | 3 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.64 | n/a | 1 | Sep 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.95 | n/a | 1 | Jan 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $5.64 | n/a | 1 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $17.92 | n/a | 1 | Nov 13, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $4.39 | n/a | 1 | Jul 24, 2013 |
Tonix Pharmaceuticals Holding
Aug 24, 2026
Reiterated: Buy
Price Target: $65
Current: $13.66
Upside: +375.84%
Pelthos Therapeutics
Aug 24, 2026
Reiterated: Buy
Price Target: $45
Current: $27.20
Upside: +65.44%
Quoin Pharmaceuticals
Aug 17, 2026
Reiterated: Buy
Price Target: $35
Current: $5.07
Upside: +590.34%
Intensity Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $30 → $15
Current: $4.90
Upside: +206.44%
Opus Genetics
Aug 7, 2026
Maintained: Buy
Price Target: $9
Current: $4.11
Upside: +118.98%
Soligenix
Aug 7, 2026
Maintained: Buy
Price Target: $1.5
Current: $0.4051
Upside: +270.28%
Barinthus Biotherapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $7 → $6
Current: $0.66
Upside: +809.09%
Adial Pharmaceuticals
Aug 3, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $5.82
Upside: +89.00%
Cybin
Jul 14, 2026
Reiterated: Buy
Price Target: $30 → $15
Current: $13.99
Upside: +7.26%
SELLAS Life Sciences Group
Jul 6, 2026
Reiterated: Buy
Price Target: $10 → $25
Current: $14.09
Upside: +77.43%
Jun 24, 2026
Reiterated: Buy
Price Target: $18
Current: $7.08
Upside: +154.24%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $3.75
Upside: +380.00%
May 26, 2026
Reiterated: Buy
Price Target: $6
Current: $1.29
Upside: +365.12%
May 21, 2026
Reiterated: Buy
Price Target: $30
Current: $0.49465
Upside: +5,964.89%
May 18, 2026
Reiterated: Buy
Price Target: $6
Current: $1.13
Upside: +430.97%
May 14, 2026
Maintained: Buy
Price Target: $3.5
Current: $1.23
Upside: +184.55%
May 14, 2026
Reiterated: Buy
Price Target: $55
Current: $33.91
Upside: +62.19%
May 14, 2026
Maintained: Buy
Price Target: $9
Current: $5.08
Upside: +77.17%
May 13, 2026
Reiterated: Buy
Price Target: $20
Current: $6.21
Upside: +222.06%
May 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.41
Upside: +609.22%
May 12, 2026
Reiterated: Buy
Price Target: $12
Current: $1.66
Upside: +622.89%
May 6, 2026
Reiterated: Buy
Price Target: $4
Current: $0.2375
Upside: +1,584.21%
Apr 6, 2026
Maintained: Buy
Price Target: $7
Current: $2.43
Upside: +188.07%
Apr 2, 2026
Reiterated: Buy
Price Target: $4.5
Current: $0.2215
Upside: +1,931.60%
Feb 19, 2026
Reiterated: Buy
Price Target: $7.5
Current: $0.3823
Upside: +1,861.81%
Nov 19, 2025
Reiterated: Buy
Price Target: $280
Current: $7.87
Upside: +3,457.81%
Jun 17, 2025
Reiterated: Buy
Price Target: $213
Current: $0.6419
Upside: n/a
May 22, 2025
Maintained: Buy
Price Target: $200 → $84
Current: $5.80
Upside: n/a
Apr 15, 2025
Maintained: Buy
Price Target: $12 → $4.5
Current: $3.32
Upside: n/a
Feb 25, 2025
Reiterated: Buy
Price Target: $19.38
Current: $3.09
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $490
Current: $5.65
Upside: n/a
Aug 13, 2024
Maintained: Buy
Price Target: $7.5
Current: $4.00
Upside: n/a
Jul 17, 2024
Initiated Coverage: Buy
Price Target: $3.5
Current: $0.3046
Upside: n/a
Jul 17, 2024
Initiated Coverage: Buy
Price Target: $10
Current: $5.40
Upside: n/a
May 2, 2024
Initiated Coverage: Buy
Price Target: $7.2
Current: $0.27
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $11
Current: $2.46
Upside: n/a
Dec 11, 2023
Initiated Coverage: Buy
Price Target: $30
Current: $1.21
Upside: n/a
Nov 10, 2023
Reiterated: Buy
Price Target: $25
Current: $8.17
Upside: n/a
May 31, 2023
Maintained: Buy
Price Target: $2.75 → $3.5
Current: $0.254
Upside: n/a
Mar 6, 2023
Initiated Coverage: Buy
Price Target: $5.5
Current: $0.0001
Upside: n/a
Jan 23, 2023
Initiated Coverage: Buy
Price Target: $80
Current: $0.074
Upside: n/a
Nov 17, 2022
Maintained: Buy
Price Target: $63 → $7
Current: $1.46
Upside: n/a
Oct 20, 2022
Initiated Coverage: Buy
Price Target: $80
Current: $5.89
Upside: n/a
Aug 25, 2022
Initiated Coverage: Buy
Price Target: $15
Current: $0.8008
Upside: n/a
Aug 5, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.1831
Upside: n/a
Jul 20, 2022
Maintained: Buy
Price Target: $13 → $4
Current: $1.66
Upside: n/a
Jul 5, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $3.48
Upside: n/a
Mar 15, 2022
Maintained: Buy
Price Target: $20 → $16
Current: $0.001
Upside: n/a
Nov 9, 2021
Maintained: Buy
Price Target: $25 → $40
Current: $5.21
Upside: n/a
Sep 3, 2021
Maintained: Buy
Price Target: $6.5
Current: $0.9317
Upside: n/a
Apr 15, 2021
Maintained: Buy
Price Target: $6.5 → $11
Current: $0.00001
Upside: n/a
Jan 21, 2021
Initiated Coverage: Buy
Price Target: $35
Current: $0.0007
Upside: n/a
Aug 10, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $5.10
Upside: n/a
Jul 13, 2020
Initiated Coverage: Buy
Price Target: $11
Current: $7.91
Upside: n/a
Oct 8, 2018
Initiated Coverage: Buy
Price Target: $50
Current: $0.06515
Upside: n/a
Jun 30, 2017
Reiterated: Buy
Price Target: $35 → $30
Current: $1.82
Upside: n/a
Sep 6, 2016
Initiated Coverage: Buy
Price Target: $20
Current: $1.64
Upside: n/a
Jan 27, 2015
Reiterated: Buy
Price Target: $25
Current: $7.95
Upside: n/a
May 15, 2014
Initiated Coverage: Buy
Price Target: $35
Current: $5.64
Upside: n/a
Nov 13, 2013
Initiated Coverage: Buy
Price Target: $30
Current: $17.92
Upside: n/a
Jul 24, 2013
Upgraded: Buy
Price Target: n/a
Current: $4.39
Upside: n/a